Maryam Norouzbahari

Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase

Fariba Peytam, Ghazaleh Takalloobanafshi, Toktam Saadattalab et al. · Scientific Reports · 2021 · 72 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +11

Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents

Ayoub Aghcheli, Mahsa Toolabi, Adileh Ayati et al. · Medicinal Chemistry Research · 2020 · 30 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety

Maryam Norouzbahari, Somayeh Salarinejad, Mümtaz Güran et al. · DARU Journal of Pharmaceutical Sciences · 2020 · 24 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13

Design, Synthesis and Characterization of Novel Urolithin Derivatives as Cholinesterase Inhibitor Agents

Maryam Norouzbahari, E. Vildan Burgaz, Tuğba Erçeti̇n et al. · Letters in Drug Design & Discovery · 2018 · 21 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis, and evaluation of novel substituted imidazo[1,2-c]quinazoline derivatives as potential α-glucosidase inhibitors with bioactivity and molecular docking insights

Fariba Peytam, Faezeh Sadat Hosseini, Reza Fathimolladehi et al. · Scientific Reports · 2024 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13